Inaktiver Wert

Response Biomedical Corp Aktie

Aktien

Dauer

Zeitraum

Stil

Response Biomedical Corp. : Completes Going-Private Transaction	29.11.16
Response Biomedical : Announces Third Quarter Results	14.11.16
Response Biomedical Corp. : Announces Third Quarter 2016 Financial Results and Update on Going-Private Transaction	10.11.16
Response Biomedical Corp. : Receives Court Approval of Going-Private Transaction	19.09.16
Response Biomedical Corp. : Receives Shareholder Approval of Going-Private Transaction	16.09.16

Manager	Titel	Alter	Seit
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-
Anastasios Tsonis DFI	Director of Finance/CFO	44	01.01.11
Eric Whitters COO	Chief Operating Officer	-	-

Aufsichtsräte	Titel	Alter	Seit
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-

Sektor

	% 1. Jan.	Kap.
BIOMÉRIEUX	-1,19 %	12,56 Mrd.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-6,06 %	7,68 Mrd.
DIASORIN S.P.A.	-0,28 %	5,29 Mrd.
LANTHEUS HOLDINGS, INC.	+21,79 %	5,24 Mrd.
AUTOBIO DIAGNOSTICS CO., LTD.	+2,05 %	4,57 Mrd.
10X GENOMICS, INC.	-51,30 %	3,29 Mrd.
ANDON HEALTH CO., LTD.	+7,80 %	2,6 Mrd.
VITROLIFE AB	-8,63 %	2,2 Mrd.
GUANGZHOU WONDFO BIOTECH CO.,LTD	-0,96 %	1,79 Mrd.